Clinical Trials Directory

Trials / Completed

CompletedNCT01288547

Effects of Theobromine and Caffeine on Mood, Cognition and Blood Pressure

Temporal Change of Mood and Cognition in Healthy Subjects After Consumption of Theobromine and/ or Caffeine

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Unilever R&D · Industry
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to measure potential mood, cognition and blood pressure effects of theobromine and caffeine in healthy women

Detailed description

Background Previous research has shown that naturally occurring chocolate ingredients theobromine and caffeine have positive effects on mood. Objectives: To assess mood and cognition in adult subjects after the consumption of capsules filled with 1. placebo, 2. theobromine alone, 3. caffeine alone or, 4. theobromine and caffeine combined together. Study design: Double-blind, placebo-controlled, randomized, cross-over design, with a 1 week washout period in between. During the 4 weeks intervention period, once a week one of the 4 types of test products were consumed with 250ml of water in a randomized order; 1. placebo capsules 2. theobromine capsules (700 mg), 3. caffeine capsules (120 mg), 4. mix of theobromine (700 mg) and caffeine (120 mg). Twenty-four healthy female subjects (and 4 reserve subjects) were recruited for a four week intervention period in total with every week a 4 hrs measurement day and one of the interventions. Primary parameters: mood (via a Bond-Lader/ caffeine visual analogue questionnaire), cognition (Digit Symbol substitution) Secondary parameters: blood pressure

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTtheobromine700 mg theobromine in gelatin capsules given one time only
DIETARY_SUPPLEMENTCaffeine120 mg caffeine in capsules given one time only
DIETARY_SUPPLEMENTcaffeine + theobromine120 mg caffeine and 700 mg theobromine in capsules given one time only
DIETARY_SUPPLEMENTplacebocellulose in capsules given one time only

Timeline

Start date
2008-05-01
Primary completion
2008-06-01
Completion
2008-07-01
First posted
2011-02-02
Last updated
2012-02-23

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01288547. Inclusion in this directory is not an endorsement.